3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Mouth Neoplasms
1
Lichen Planus
1
Leukokeratosis, Hereditary Mucosal
1
Fanconi Anemia
1
Erythroplasia
1
Interventions
Human Papillomavirus DNA Tests
4
Colposcopy
4
Watchful Waiting
3
Biopsy
3
Acetic Acid
3
Transurethral Resection of Prostate
2
Restraint, Physical
2
Conization
2
Blood Specimen Collection
2
pembrolizumab
1
human papillomavirus vaccine, L1 type 16, 18
1
fludarabine phosphate
1
fludarabine
1
epigallocatechin gallate
1
artesunic acid
1
artemisinin
1
aldesleukin
1
Vaccines
1
Ultrasonography, Doppler
1
Transdermal Patch
1
Respiratory Function Tests
1
Prochlorperazine
1
Pregnancy Tests
1
Positron-Emission Tomography
1
Papanicolaou Test
1
Ondansetron
1
O(6)-codeine methyl ether
1
Nicotine Replacement Therapy
1
Mutagenesis, Insertional
1
Molecular Diagnostic Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Dysplasia
×
Molecular Diagnostic Techniques
×
1 year
×
Clear all
NCT02328872
2026-04-17
Compass
VCS Foundation
Phase NA
Active not recruiting
76,181 enrolled